Logo image of VER-H.CA

VERISANTE TECHNOLOGY INC (VER-H.CA) Stock Fundamental Analysis

TSX-V:VER-H - TSX Venture Exchange - CA92346G2036 - Common Stock - Currency: CAD

0.015  0 (0%)

Fundamental Rating

0

VER-H gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 16 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of VER-H have multiple concerns. VER-H has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VER-H had negative earnings in the past year.
VER-H had a negative operating cash flow in the past year.
In the past 5 years VER-H reported 4 times negative net income.
In the past 5 years VER-H reported 4 times negative operating cash flow.
VER-H.CA Yearly Net Income VS EBIT VS OCF VS FCFVER-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M

1.2 Ratios

VER-H's Return On Assets of -1212.50% is on the low side compared to the rest of the industry. VER-H is outperformed by 93.75% of its industry peers.
Industry RankSector Rank
ROA -1212.5%
ROE N/A
ROIC N/A
ROA(3y)326.88%
ROA(5y)16.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VER-H.CA Yearly ROA, ROE, ROICVER-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K -20K -25K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VER-H so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VER-H.CA Yearly Profit, Operating, Gross MarginsVER-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K -5K

More info and screens

1

2. Health

2.1 Basic Checks

VER-H has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VER-H has been increased compared to 5 years ago.
VER-H has a worse debt/assets ratio than last year.
VER-H.CA Yearly Shares OutstandingVER-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
VER-H.CA Yearly Total Debt VS Total AssetsVER-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M

2.2 Solvency

VER-H has an Altman-Z score of -3280.02. This is a bad value and indicates that VER-H is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -3280.02, VER-H is not doing good in the industry: 93.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3280.02
ROIC/WACCN/A
WACCN/A
VER-H.CA Yearly LT Debt VS Equity VS FCFVER-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M

2.3 Liquidity

VER-H has a Current Ratio of 1.04. This is a normal value and indicates that VER-H is financially healthy and should not expect problems in meeting its short term obligations.
VER-H's Current ratio of 1.04 is in line compared to the rest of the industry. VER-H outperforms 43.75% of its industry peers.
VER-H has a Quick Ratio of 1.04. This is a normal value and indicates that VER-H is financially healthy and should not expect problems in meeting its short term obligations.
VER-H has a Quick ratio of 1.04. This is comparable to the rest of the industry: VER-H outperforms 56.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
VER-H.CA Yearly Current Assets VS Current LiabilitesVER-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for VER-H have decreased strongly by -106.00% in the last year.
EPS 1Y (TTM)-106%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VER-H.CA Yearly Revenue VS EstimatesVER-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 50K 100K 150K 200K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
VER-H.CA Price Earnings VS Forward Price EarningsVER-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VER-H.CA Per share dataVER-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VER-H does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERISANTE TECHNOLOGY INC

TSX-V:VER-H (5/1/2025, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners75.52%
Ins Owner ChangeN/A
Market Cap659.10K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1212.5%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)326.88%
ROA(5y)16.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z -3280.02
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.7%
OCF growth 3YN/A
OCF growth 5YN/A